PropertyValue
?:abstract
  • Much has changed in the medical treatment of COVID-19 after the first patient with an infection with SARS-CoV-2 in the Netherlands was diagnosed in February 2020 On the basis of limited data, at first only off-label use of (hydroxy)chloroquine seemed to be a treatment option However, now based on the findings of several randomized studies, other medicines have been included in the Dutch guidelines about the treatment of COVID-19 In this article, we will briefly discuss the current state of affairs with regard to the drugs (hydroxy) chloroquine, remdesivir and corticosteroids Again, it appears that only well-executed randomized clinical trials can determine the status of various supposedly effective drugs
is ?:annotates of
?:creator
?:journal
  • Ned_Tijdschr_Geneeskd
?:license
  • unk
?:publication_isRelatedTo_Disease
is ?:relation_isRelatedTo_publication of
?:source
  • WHO
?:title
  • [The medicinal treatment of COVID-19: a brief update]
?:type
?:who_covidence_id
  • #979350
?:year
  • 2020

Metadata

Anon_0  
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://purl.org/net/provenance/ns#DataItem>
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2004/03/trix/rdfg-1/Graph>
<http://xmlns.com/foaf/0.1/primaryTopic> <https://research.tib.eu/covid-19/entity/acysqnr2>
<http://xmlns.com/foaf/0.1/topic> Anon_0
<http://www.ontologydesignpatterns.org/cp/owl/informationrealization.owl#realizes> <https://research.tib.eu/covid-19/data/entity/acysqnr2>
<http://purl.org/net/provenance/ns#createdBy>
Anon_1   (more)
expand all